Thomas is the Managing Director of PRO-LIANCE GLOBAL SOLUTIONS GmbH and brings over two decades of experience in Regulatory and Clinical Affairs for medical devices and pharmaceuticals. With a scientific background in biochemistry and molecular biology, he supports the EASYGEN Consortium by shaping regulatory strategies and contributing to the development of proposals that address current gaps inthe regulatory framework for automated point-of-care manufacturing of cellularand genetic therapies (CGTs). His consulting work focuses on clinical and biological evaluations, with a strong emphasis on aligning scientific innovation with evolving regulatory requirements.

‍